KZIA Kazia Therapeutics Limited - American Depositary Shares
$13.35
Price · Aug 25, 2026
Fundamentals as of Nov 7, 2006
52W Range
$5–$17
68% of range
Analyst Rating
BUY
11 analysts
Price Target
$29
+114% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
KZIA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$13.35
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$5 – $17
KZIA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
KZIA
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
KZIA
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
KZIA
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
KZIA
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
KZIA
Peer Median
KZIA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
11 analysts
- Strong Buy 3 27.3%
- Buy 7 63.6%
- Hold 1 9.1%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
6 analysts · 2026-08-22
Median
$30.11
Mean
$28.55
← Below all targets
$13.35
Low
$17.97
High
$34.80
Median target
$30.11
+125.6%
Mean target
$28.55
+114.0%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-7.6%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| Dec. 31, 2025 | $-0.81 | $-0.33 | -0.47% |
| June 30, 2025 | $1.42 | $-1.33 | 2.7% |
| Dec. 31, 2024 | $-12.30 | $-17.44 | 5.1% |
| June 30, 2023 | $-9.50 | $-2.55 | -7.0% |
| June 30, 2022 | $-43.55 | $-5.10 | -38.5% |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 41 filers · $53.4M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 23 (+16 vs prior Q) | 5 (-1 vs prior Q) | 9 (+3 vs prior Q) | 4 (0 vs prior Q) | +2.1M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Boxer Capital Management, LLC | $7,884,800 | 560,000 | 14.78% | Shares |
| FLPUTNAM INVESTMENT MANAGEMENT CO | $5,842,609 | 414,958 | 10.95% | Shares |
| Bleichroeder LP | $5,632,000 | 400,000 | 10.56% | Shares |
| Ikarian Capital, LLC | $5,578,510 | 396,201 | 10.45% | Shares |
| Dauntless Investment Group, LLC | $4,987,249 | 354,208 | 9.35% | Shares |
| Stonepine Capital Management, LLC | $4,860,120 | 345,179 | 9.11% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3,543,936 | 251,700 | 6.64% | Call option |
| Point72 Asset Management, L.P. | $2,304,224 | 200,300 | 4.32% | Shares |
| Ensign Peak Advisors, Inc | $1,559,754 | 110,778 | 2.92% | Shares |
| MILLENNIUM MANAGEMENT LLC | $1,427,374 | 101,376 | 2.68% | Shares |
| CITADEL ADVISORS LLC | $1,070,080 | 76,000 | 2.01% | Call option |
| J. Goldman & Co LP | $964,353 | 68,491 | 1.81% | Shares |
| ADAR1 Capital Management, LLC | $866,624 | 61,550 | 1.62% | Shares |
| JANE STREET GROUP, LLC | $803,405 | 57,060 | 1.51% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $712,673 | 50,616 | 1.34% | Shares |
| COOPERMAN LEON G | $704,000 | 50,000 | 1.32% | Shares |
| Westside Investment Management, Inc. | $669,997 | 47,585 | 1.26% | Shares |
| JANE STREET GROUP, LLC | $506,880 | 36,000 | 0.95% | Call option |
| BARCLAYS PLC | $464,640 | 33,000 | 0.87% | Shares |
| XTX Topco Ltd | $439,099 | 31,186 | 0.82% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $430,848 | 30,600 | 0.81% | Put option |
| BNP PARIBAS FINANCIAL MARKETS | $423,667 | 30,090 | 0.79% | Shares |
| RAYMOND JAMES FINANCIAL INC | $318,194 | 22,599 | 0.60% | Shares |
| Sequoia Financial Advisors, LLC | $281,643 | 20,003 | 0.53% | Shares |
| Engineers Gate Manager LP | $210,848 | 14,975 | 0.40% | Shares |
| MORGAN STANLEY | $206,835 | 14,690 | 0.39% | Shares |
| Laird Norton Wetherby Trust Company, LLC | $181,632 | 12,900 | 0.34% | Shares |
| UNITED BANK | $180,941 | 12,851 | 0.34% | Shares |
| Rockefeller Capital Management L.P. | $178,816 | 12,700 | 0.34% | Shares |
| JPMORGAN CHASE & CO | $41,399 | 2,863 | 0.08% | Shares |
| GAMMA Investing LLC | $27,118 | 1,926 | 0.05% | Shares |
| RAYMOND JAMES FINANCIAL INC | $20,000 | 2,000 | 0.04% | Call option |
| RHUMBLINE ADVISERS | $18,245 | 1,296 | 0.03% | Shares |
| MARSHALL WACE, LLP | $10,602 | 753 | 0.02% | Shares |
| CITADEL ADVISORS LLC | $2,253 | 160 | 0.00% | Shares |
| Arax Advisory Partners | $1,225 | 87 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $338 | 24 | 0.00% | Shares |
| Integrated Wealth Concepts LLC | $282 | 20 | 0.00% | Shares |
| OSAIC HOLDINGS, INC. | $140 | 10 | 0.00% | Shares |
| Allworth Financial LP | $15 | 1 | 0.00% | Shares |
| UBS Group AG | $14 | 1 | 0.00% | Shares |
Company insiders 9 insiders · 5 officers · 3 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| John E. Friend II | Chief Executive Officer | Jan. 8, 2026 A | — | 0 | 0 | $0 |
| James E. Levine | Chief Financial Officer | June 19, 2026 A | — | 0 | 0 | $0 |
| Sudha Rao | Chief Scientific Officer | June 19, 2026 A | — | 0 | 0 | $0 |
| David Cain | Director, CMC | Jan. 8, 2026 A | — | 0 | 0 | $0 |
| Jeffrey Bonacorda | VP, Finance and Controller | Jan. 8, 2026 A | — | 0 | 0 | $0 |
| Ebru Davidson | Director | Jan. 8, 2026 A | — | 0 | 0 | $0 |
| Steven R. S. Coffey | Director | Jan. 8, 2026 A | — | 0 | 0 | $0 |
| Robert F Apple | Director | Jan. 8, 2026 A | — | 0 | 0 | $0 |
| NOVOGEN LTD | 10% owner | Dec. 3, 2012 J | 0 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 4 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| SS. OR ×13 filings | Nov. 25, 2013 | — | Initial filing | — | SEC |
| Novogen Limited (2) ×6 filings | Dec. 7, 2012 | — | Initial filing | M&A / sale | SEC |
| Novogen Limited ×2 filings | May 11, 2011 | — | Initial filing | M&A / sale | SEC |
| Undisclosed reporting person, Undisclosed reporting person | April 4, 2006 | — | Initial filing | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 1 ETF
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| APIE · Trust for Professional Managers | 0.00% | 3,251 NS | May 31, 2026 | N-PORT |